Home » Evidence

HUMANS generates clinical evidence

Real World Evidence

Humans generates clinical evidence on the use and potential benefits or risks of a medical product, which is analyzed through advanced analytical processing that allows, for example, to classify variables with the greatest impact on treatment.

Increase
of compensated patients

Humans, applied to the treatment of type 2 diabetes has shown a 25% increase in compensated patients in 6 months of treatment.

INSIGHTS
5/5
Easy to use
Fast to use
It helps
User-friendly interface
Useful recommendations
Pilot
January - August 2021
  • Hospital de San Vicente
  • 6 Months
  • 28 Patients
  • 6 months of telemonitoring
  • 360 glycemias per patient
  • 10,080 total glycemias

Real World Evidence

* Results obtained from the pilot conducted in San Vicente Hospital, Chile, with continuous follow-up of 28 type II diabetic patients between January and August 2021.

* At the beginning of the study, 50% of the patients were decompensated (HbA1c over 9%, represented by group A). With the use of the tool we evaluated a 25% improvement in compensated patients. Group B presented a slight worsening, remaining between 7-9% HbA1c. Group C remains in optimal conditions with HbA1c < 7%.